shiga-like toxins neutralized tailored multivalent carbohydrate ligands 
diseases caused shiga cholera toxins account loss millions lives year1 belong clinically significant subset bacterial ab5 toxins consisting enzymatically active subunit gains entry susceptible mammalian cells oligosaccharide recognition b- homopentamer23 therapies might target obligatory oligosaccharide-toxin recognition event4 low intrinsic affinity carbohydrate-protein interactions hampers development low-molecular-weight inhibitors5 toxins circumvent low affinity binding simultaneously five cell-surface carbohydrates6 demonstrate use crystal structure b- subunit escherichia coli o157:h7 shiga-like toxin slt-i complex analogue carbohydrate receptor6 design oligovalent water-soluble carbohydrate ligand named starfish subnanomolar inhibitory activity vitro inhibitory activity --million-fold higher univalent ligands far highest molar activity inhibitor yet reported shiga-like toxins ii crystallography starfish/shiga-like toxin complex explains activity two trisaccharide receptors tips five spacer arms simultaneously engage five b subunits two toxin molecules 
